{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:24:20Z","timestamp":1783092260666,"version":"3.54.6"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Scientific Research Projects Coordination Unit of Afyonkarahisar Health Sciences University","award":["Project No: 19.TIP.008"],"award-info":[{"award-number":["Project No: 19.TIP.008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-026-04863-0","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T03:05:05Z","timestamp":1778468705000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of coenzyme Q10 on retinal inflammation in streptozotocin-induced diabetic rats"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4846-312X","authenticated-orcid":false,"given":"M\u00fcberra","family":"Akdo\u011fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2106-2422","authenticated-orcid":false,"given":"\u00c7i\u011fdem","family":"Karaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4795-2266","authenticated-orcid":false,"given":"Hasan H\u00fcseyin","family":"Demirel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"4863_CR1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1001\/jamaophthalmol.2018.6399","volume":"137","author":"EY Kang","year":"2019","unstructured":"Kang EY, Chen TH, Garg SJ, Sun CC, Kang JH, Wu WC, et al. Association of statin therapy with prevention of vision-threatening diabetic retinopathy. JAMA Ophthalmol. 2019;137:363\u201371.","journal-title":"JAMA Ophthalmol"},{"key":"4863_CR2","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/jdi.13480","volume":"12","author":"KY Lin","year":"2021","unstructured":"Lin KY, Hsih WH, Lin YB, Wen CY, Chang TJ. Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy. J Diabetes Investig. 2021;12:1322\u20135.","journal-title":"J Diabetes Investig"},{"key":"4863_CR3","doi-asserted-by":"crossref","unstructured":"Olivares AM, Althoff K, Chen GF, Wu S, Morrisson MA, DeAngelis, et al. Animal models of diabetic retinopathy. Curr Diab Rep. 2017;17(10)\u201393.","DOI":"10.1007\/s11892-017-0913-0"},{"key":"4863_CR4","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3390\/ijms19061816","volume":"19","author":"W Wang","year":"2018","unstructured":"Wang W, Lo ACY. Diabetic retinopathy: pathophysiology and treatments. Int J Mol Sci. 2018;19:1816.","journal-title":"Int J Mol Sci"},{"key":"4863_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4103\/0974-9233.92118","volume":"19","author":"AM El-Asrar","year":"2012","unstructured":"El-Asrar AM. Role of inflammation in the pathogenesis of diabetic retinopathy. Middle East Afr J Ophthalmol. 2012;19:70\u20134.","journal-title":"Middle East Afr J Ophthalmol"},{"key":"4863_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/hmg\/ddh008","volume":"13","author":"AS Karban","year":"2004","unstructured":"Karban AS, Okazaki T, Panhuysen CIM, Gallegos T, Potter JJ, Bailey-Wilson JE, et al. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet. 2004;13:35\u201345.","journal-title":"Hum Mol Genet"},{"key":"4863_CR7","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S0002-9440(10)64970-X","volume":"156","author":"F Podest\u00e0","year":"2000","unstructured":"Podest\u00e0 F, Romeo G, Liu W-H, Krajewski S, Reed JC, Gerhardinger C, et al. Bax Is Increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. Am J Pathol. 2000;156:1025\u201332.","journal-title":"Am J Pathol"},{"key":"4863_CR8","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1136\/bjo.2007.132308","volume":"92","author":"T Oshitari","year":"2008","unstructured":"Oshitari T, Yamamoto S, Hata N, Roy S. Mitochondria- and caspase-dependent cell death pathway involved in neuronal degeneration in diabetic retinopathy. Br J Ophthalmol. 2008;92:552\u20136.","journal-title":"Br J Ophthalmol"},{"key":"4863_CR9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.expneurol.2004.05.003","volume":"188","author":"CW Shults","year":"2004","unstructured":"Shults CW, Flint Beal M, Song D, Fontaine D. Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson\u2019s disease. Exp Neurol. 2004;188:491\u20134.","journal-title":"Exp Neurol"},{"key":"4863_CR10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.pharmthera.2005.02.002","volume":"107","author":"CW Shults","year":"2005","unstructured":"Shults CW. Therapeutic role of coenzyme Q10 in Parkinson\u2019s disease. Pharmacol Ther. 2005;107:120\u201330.","journal-title":"Pharmacol Ther"},{"key":"4863_CR11","doi-asserted-by":"publisher","first-page":"H785","DOI":"10.1111\/1750-3841.12116","volume":"78","author":"H Moon","year":"2013","unstructured":"Moon H, Ko W, Jung M, Kim JH, Lee W, Park K, et al. Coenzyme Q10 regulates osteoclast and osteoblast differentiation. J Food Sci. 2013;78:H785\u201391.","journal-title":"J Food Sci"},{"key":"4863_CR12","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1167\/iovs.08-2656","volume":"50","author":"J Qu","year":"2009","unstructured":"Qu J, Kaufman Y, Washington I. Coenzyme Q10 in the human retina. Invest Ophthalmol Vis Sci. 2009;50:1814\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4863_CR13","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1177\/1120672120972026","volume":"32","author":"JM Serrano-Morales","year":"2020","unstructured":"Serrano-Morales JM, De-Hita-Cantalejo C, S\u00e1nchez-Gonz\u00e1lez MC, Bautista-Llamas MJ, S\u00e1nchez-Gonz\u00e1lez JM. Efficacy of 0.1% crosslinked hyaluronic acid, coenzyme Q10 and vitamin E in the management of dry eye disease in menopause patients receiving antidepressants. Eur J Ophthalmol. 2020;32:658\u201363.","journal-title":"Eur J Ophthalmol"},{"key":"4863_CR14","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1111\/j.1755-3768.2009.01632.x","volume":"88","author":"R Fato","year":"2010","unstructured":"Fato R, Bergamini C, Leoni S, Pinna A, Carta F, Cardascia N, et al. Coenzyme Q10 vitreous levels after administration of coenzyme Q10 eyedrops in patients undergoing vitrectomy. Acta Ophthalmol. 2010;88:e150\u20131.","journal-title":"Acta Ophthalmol"},{"key":"4863_CR15","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1167\/iovs.05-0272","volume":"47","author":"H Luan","year":"2006","unstructured":"Luan H, Roberts R, Sniegowski M, Goebel DJ, Berkowitz BA. Retinal thickness and subnormal retinal oxygenation response in experimental diabetic retinopathy. Invest Ophthalmol Vis Sci. 2006;47:320\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4863_CR16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3390\/antiox7110160","volume":"7","author":"KD Beharry","year":"2018","unstructured":"Beharry KD, Cai CL, Siddiqui F, Chowdhury S, D\u2019Agrosa C, Valencia GB, et al. Comparative effects of coenzyme Q10 or n-3 polyunsaturated fatty acid supplementation on retinal angiogenesis in a rat model of oxygen-induced retinopathy. Antioxidants. 2018;7:160.","journal-title":"Antioxidants"},{"key":"4863_CR17","first-page":"849","volume":"43","author":"AN Witmer","year":"2002","unstructured":"Witmer AN, Blaauwgeers HG, Weich HA, Alitalo K, Vrensen GF, Schlingemann RO. Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey. Invest Ophthalmol Vis Sci. 2002;43:849\u201357.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4863_CR18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1755-3768.2010.02010.x","volume":"89","author":"M Waisbourd","year":"2011","unstructured":"Waisbourd M, Goldstein M, Loewenstein A. Treatment of diabetic retinopathy with anti-VEGF drugs. Acta Ophthalmol. 2011;89:203\u20137.","journal-title":"Acta Ophthalmol"},{"key":"4863_CR19","doi-asserted-by":"publisher","first-page":"893","DOI":"10.2337\/dc13-2002","volume":"37","author":"R Sim\u00f3","year":"2014","unstructured":"Sim\u00f3 R, Sundstrom JM, Antonetti DA. Ocular anti-VEGF therapy for diabetic retinopathy: the role of vegf in the pathogenesis of diabetic retinopathy. Diabetes Care. 2014;37:893\u20139.","journal-title":"Diabetes Care"},{"key":"4863_CR20","doi-asserted-by":"publisher","first-page":"629452","DOI":"10.1155\/2012\/629452","volume":"2012","author":"D Gologorsky","year":"2012","unstructured":"Gologorsky D, Thanos A, Vavvas D. Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy. Mediators Inflamm. 2012;2012:629452.","journal-title":"Mediators Inflamm"},{"key":"4863_CR21","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/dme.12640","volume":"32","author":"MB Sasongko","year":"2015","unstructured":"Sasongko MB, Wong TY, Jenkins AJ, Nguyen TT, Shaw JE, Wang JJ. Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy. Diabet Med. 2015;32:686\u201391.","journal-title":"Diabet Med"},{"key":"4863_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0140-6736(64)90008-X","volume":"284","author":"EU Powell","year":"1964","unstructured":"Powell EU, Field R. Diabetic retinopathy and rheumatoid arthritis. Lancet. 1964;284:17\u20138.","journal-title":"Lancet"},{"key":"4863_CR23","doi-asserted-by":"publisher","first-page":"8546423","DOI":"10.1155\/2018\/8546423","volume":"2018","author":"S Feng","year":"2018","unstructured":"Feng S, Yu H, Yu Y, Geng Y, Li D, Yang C, et al. Levels of inflammatory cytokines IL-1\u03b2, IL-6, IL-8, IL-17A, and TNF-\u03b1 in aqueous humour of patients with diabetic retinopathy. J Diabetes Res. 2018;2018:8546423.","journal-title":"J Diabetes Res"},{"key":"4863_CR24","doi-asserted-by":"publisher","first-page":"627","DOI":"10.4103\/0253-7613.144924","volume":"46","author":"R Maheshwari","year":"2014","unstructured":"Maheshwari R, Balaraman R, Sen A, Seth A. Effect of coenzyme Q10 alone and its combination with metformin on streptozotocin-nicotinamide-induced diabetic nephropathy in rats. Indian J Pharmacol. 2014;46:627.","journal-title":"Indian J Pharmacol"},{"key":"4863_CR25","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s12035-016-9765-x","volume":"54","author":"TK Motawi","year":"2017","unstructured":"Motawi TK, Darwish HA, Hamed MA, El-Rigal NS, Naser AFA. A therapeutic insight of niacin and coenzyme Q10 against diabetic encephalopathy in rats. Mol Neurobiol. 2017;54:1601\u201311.","journal-title":"Mol Neurobiol"},{"key":"4863_CR26","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/BF03401589","volume":"1","author":"HP Hammes","year":"1995","unstructured":"Hammes HP, Federoff HJ, Brownlee M. Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes. Mol Med. 1995;1:527\u201334.","journal-title":"Mol Med"},{"key":"4863_CR27","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1167\/iovs.04-1340","volume":"46","author":"AJ Barber","year":"2005","unstructured":"Barber AJ, Antonetti DA, Kern TS, Reiter CEN, Soans RS, Krady JK, et al. The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci. 2005;46:2210\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4863_CR28","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1167\/iovs.04-0247","volume":"45","author":"PM Martin","year":"2004","unstructured":"Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB. Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci. 2004;45:3330\u20136.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4863_CR29","doi-asserted-by":"publisher","first-page":"8295","DOI":"10.1167\/iovs.12-10374","volume":"53","author":"M Lulli","year":"2012","unstructured":"Lulli M, Witort E, Papucci L, Torre E, Schipani C, Bergamini C, et al. Coenzyme Q10 instilled as eye drops on the cornea reaches the retina and protects retinal layers from apoptosis in a mouse model of kainate-induced retinal damage. Invest Ophthalmol Vis Sci. 2012;53:8295\u2013302.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4863_CR30","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/jrr\/rrs025","volume":"53","author":"M Lulli","year":"2012","unstructured":"Lulli M, Witort E, Papucci L, Torre E, Schiavone N, Dal Monte M, et al. Coenzyme Q10 protects retinal cells from apoptosis induced by radiation in vitro and in vivo. J Radiat Res. 2012;53:695\u2013703.","journal-title":"J Radiat Res"},{"key":"4863_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/1099-0461(2001)15:1<41::AID-JBT5>3.0.CO;2-Z","volume":"15","author":"FM Rauscher","year":"2001","unstructured":"Rauscher FM, Sanders RA, Watkins JB. Effects of coenzyme Q10 treatment on antioxidant pathways in normal and streptozotocin-induced diabetic rats. J Biochem Mol Toxicol. 2001;15:41\u20136.","journal-title":"J Biochem Mol Toxicol"},{"key":"4863_CR32","doi-asserted-by":"publisher","first-page":"8562408","DOI":"10.1155\/2019\/8562408","volume":"2019","author":"OM Cecilia","year":"2019","unstructured":"Cecilia OM, Jos\u00e9 Alberto CG, Jos\u00e9 NP, Ernesto Germ\u00e1n CM, Ana Karen LC, Luis Miguel RP, et al. Oxidative stress as the main target in diabetic retinopathy pathophysiology. J Diabetes Res. 2019;2019:8562408.","journal-title":"J Diabetes Res"},{"key":"4863_CR33","doi-asserted-by":"publisher","first-page":"5072","DOI":"10.3390\/ijms24065072","volume":"24","author":"C Garc\u00eda-L\u00f3pez","year":"2023","unstructured":"Garc\u00eda-L\u00f3pez C, Garc\u00eda-L\u00f3pez V, Matamoros JA, Fern\u00e1ndez-Albarral JA, Salobrar-Garc\u00eda E, de Hoz R, et al. The role of citicoline and coenzyme Q10 in retinal pathology. Int J Mol Sci. 2023;24:5072.","journal-title":"Int J Mol Sci"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-026-04863-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-04863-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-04863-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:11:05Z","timestamp":1783091465000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-026-04863-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4863"],"URL":"https:\/\/doi.org\/10.1186\/s12886-026-04863-0","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"7 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures were approved by the Animal Experiments Local Ethics Committee of Afyonkarahisar Health Sciences University (Approval No: 49533702\/146, Date: 26.11.2021). All procedures were conducted in accordance with the ARRIVE guidelines and the National Institutes of Health Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"375"}}